Literature DB >> 7522056

The integrin alpha v gene: identification and characterization of the promoter region.

J P Donahue1, N Sugg, J Hawiger.   

Abstract

We isolated a 15.5 kilobase pair DNA fragment that contains the 5' end of the human vitronectin receptor alpha subunit (alpha v) gene. The nucleotide sequence of the 5' flanking region, first exon and part of the first intron of the alpha v gene was determined. The sequence showed that the 5' end of the alpha v gene lies within a CpG island. The transcriptional initiation site was mapped 169 base pairs upstream of the alpha v translational initiation site. The 5' flanking region of the alpha v gene does not contain TATA or InR transcriptional control elements but does contain four Sp1 binding sites, two Ets binding sites and one GATA binding site. The identified alpha v gene 5' flanking region directed the expression of human growth hormone in transfected HeLa cells. Successive deletions of the 5' flanking region demonstrated a 222 bp region that exerts a strong positive effect on alpha v promoter activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522056     DOI: 10.1016/0167-4781(94)90278-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells.

Authors:  Wei Wu; Yi Wei Dong; Peng Cheng Shi; Mei Yu; Da Fu; Chun Yi Zhang; Qian Qian Cai; Qian Lei Zhao; Ming Peng; Li Hui Wu; Xing Zhong Wu
Journal:  J Lipid Res       Date:  2013-01-22       Impact factor: 5.922

Review 2.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

3.  Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding.

Authors:  Suzanne Bartholf DeWitt; Sarah Hoskinson Plumlee; Hailey E Brighton; Dharshan Sivaraj; E J Martz; Maryam Zand; Vardhman Kumar; Maya U Sheth; Warren Floyd; Jacob V Spruance; Nathan Hawkey; Shyni Varghese; Jianhua Ruan; David G Kirsch; Jason A Somarelli; Ben Alman; William C Eward
Journal:  JCI Insight       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.